Marshall Wace, LLP Anika Therapeutics, Inc. Transaction History
Marshall Wace, LLP
- $63.3 Billion
- Q1 2024
A detailed history of Marshall Wace, LLP transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 34,292 shares of ANIK stock, worth $879,932. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,292
Previous 20,572
66.69%
Holding current value
$879,932
Previous $466,000
86.91%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ANIK
# of Institutions
119Shares Held
11.9MCall Options Held
5.9KPut Options Held
6.3K-
Trigran Investments, Inc.2.07MShares$53.2 Million5.1% of portfolio
-
Black Rock Inc. New York, NY1.56MShares$40.1 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX810KShares$20.8 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA774KShares$19.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY702KShares$18 Million0.0% of portfolio
About Anika Therapeutics, Inc.
- Ticker ANIK
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,599,900
- Market Cap $375M
- Description
- Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...